| A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme MR Rosenfeld, X Ye, JG Supko, S Desideri, SA Grossman, S Brem, ... Autophagy 10 (8), 1359-1368, 2014 | 480 | 2014 |
| Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma R Rangwala, YC Chang, J Hu, KM Algazy, TL Evans, LA Fecher, ... Autophagy 10 (8), 1391-1402, 2014 | 429 | 2014 |
| Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma R Rangwala, R Leone, YC Chang, LA Fecher, LM Schuchter, A Kramer, ... Autophagy 10 (8), 1369-1379, 2014 | 359 | 2014 |
| CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment A DeMichele, AS Clark, KS Tan, DF Heitjan, K Gramlich, M Gallagher, ... Clinical Cancer Research 21 (5), 995-1001, 2015 | 357 | 2015 |
| Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma DT Vogl, EA Stadtmauer, KS Tan, DF Heitjan, LE Davis, L Pontiggia, ... Autophagy 10 (8), 1380-1390, 2014 | 356 | 2014 |
| Screening outcomes following implementation of digital breast tomosynthesis in a general-population screening program AM McCarthy, D Kontos, M Synnestvedt, KS Tan, DF Heitjan, M Schnall, ... Journal of the National Cancer Institute 106 (11), dju316, 2014 | 205 | 2014 |
| Trends in critical care beds and use among population groups and Medicare and Medicaid beneficiaries in the United States: 2000–2010 NA Halpern, DA Goldman, KS Tan, SM Pastores Critical care medicine 44 (8), 1490, 2016 | 200 | 2016 |
| A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti–PD-1 agent pembrolizumab PS Adusumilli, MG Zauderer, I Rivière, SB Solomon, VW Rusch, ... Cancer discovery 11 (11), 2748-2763, 2021 | 191 | 2021 |
| Impact of increasing age on cause-specific mortality and morbidity in patients with stage I non–small-cell lung cancer: a competing risks analysis T Eguchi, S Bains, MC Lee, KS Tan, B Hristov, DH Buitrago, MS Bains, ... Journal of Clinical Oncology 35 (3), 281, 2017 | 179 | 2017 |
| The impact of EBV status on characteristics and outcomes of posttransplantation lymphoproliferative disorder MR Luskin, DS Heil, KS Tan, S Choi, EA Stadtmauer, SJ Schuster, ... American Journal of Transplantation 15 (10), 2665-2673, 2015 | 152 | 2015 |
| Lobectomy is associated with better outcomes than sublobar resection in spread through air spaces (STAS)-positive T1 lung adenocarcinoma: a propensity score–matched analysis T Eguchi, K Kameda, S Lu, MJ Bott, KS Tan, J Montecalvo, JC Chang, ... Journal of thoracic oncology 14 (1), 87-98, 2019 | 144 | 2019 |
| Spread through air spaces (STAS) is an independent predictor of recurrence and lung cancer–specific death in squamous cell carcinoma S Lu, KS Tan, K Kadota, T Eguchi, S Bains, N Rekhtman, PS Adusumilli, ... Journal of Thoracic Oncology 12 (2), 223-234, 2017 | 141 | 2017 |
| Is enhanced recovery the new standard of care in microsurgical breast reconstruction? A Afonso, S Oskar, KS Tan, JJ Disa, BJ Mehrara, J Ceyhan, JH Dayan Plastic and reconstructive surgery 139 (5), 1053, 2017 | 107 | 2017 |
| Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma NP Chudgar, MF Brennan, RR Munhoz, PR Bucciarelli, KS Tan, ... The Journal of thoracic and cardiovascular surgery 154 (1), 319-330. e1, 2017 | 104 | 2017 |
| Safety and feasibility of lung resection after immunotherapy for metastatic or unresectable tumors MJ Bott, J Cools-Lartigue, KS Tan, J Dycoco, MS Bains, RJ Downey, ... The Annals of thoracic surgery 106 (1), 178-183, 2018 | 98 | 2018 |
| United States resource availability for COVID-19 NA Halpern, KS Tan Society of Critical Care Medicine 3, 1-16, 2020 | 94 | 2020 |
| Goal-directed fluid therapy using stroke volume variation for resuscitation after low central venous pressure-assisted liver resection: a randomized clinical trial C Correa-Gallego, KS Tan, V Arslan-Carlon, M Gonen, SC Denis, ... Journal of the American College of Surgeons 221 (2), 591-601, 2015 | 86 | 2015 |
| Pilot and feasibility trial evaluating immuno-gene therapy of malignant mesothelioma using intrapleural delivery of adenovirus-IFNα combined with chemotherapy DH Sterman, E Alley, JP Stevenson, J Friedberg, S Metzger, A Recio, ... Clinical Cancer Research 22 (15), 3791-3800, 2016 | 83 | 2016 |
| Pathologic assessment after neoadjuvant chemotherapy for NSCLC: importance and implications of distinguishing adenocarcinoma from squamous cell carcinoma Y Qu, K Emoto, T Eguchi, RG Aly, H Zheng, JE Chaft, KS Tan, DR Jones, ... Journal of Thoracic Oncology 14 (3), 482-493, 2019 | 82 | 2019 |
| The relationships between coping, occupational stress, and emotional intelligence in newly hired oncology nurses AM Mazzella Ebstein, L Sanzero Eller, KS Tan, C Cherniss, JS Ruggiero, ... Psycho‐oncology 28 (2), 278-283, 2019 | 78 | 2019 |
